Allan RyanFeb 27, 20232 minInvestigational melanoma vaccine receives breakthrough designation from U.S. FDAData from a Phase 2b study indicates that an investigational personalized mRNA cancer vaccine known as mRNA-4157/V940, in combination...
John EvansSep 24, 20212 minPembrolizumab lowered risk of stage IIb/c melanoma recurrence The immunotherapy medication pembrolizumab, approved for the treatment of stage III and IV melanoma, has been shown to reduce...
Cory PerlaFeb 10, 20211 minVIDEO: Fecal microbiota transplant may help melanoma patients respond to immunotherapyA proof-of-principle study has found that fecal transplants may help advanced melanoma patients respond to immunotherapy better.